N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide

C137H161F3N10O11S2 — CID 162025491

IUPACN-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide
SMILESCC1(CCCCC[C@H](NC(=O)c2ccc(-c3ccccc3)cc2)C(=O)N2CCCCC2)C[C@H]1c1ccc(F)cc1.CCN1CCN(C(=O)[C@H](CS(=O)(=O)CCCC2(C)C[C@H]2c2ccc(F)cc2)NC(=O)c2ccc(-c3ccccc3)cc2)CC1.COc1ccc([C@@H]2CC2(C)CCCNC[C@H](NC(=O)c2ccc(-c3ccccc3)cc2)C(=O)N2CCCC2)cc1.O=C(N[C@@H](CSCCCC1C[C@H]1c1ccc(F)cc1)C(=O)N1CCCCC1)c1ccc(-c2ccccc2)cc1
InChIInChI=1S/C35H42FN3O4S.C35H41FN2O2.C34H41N3O3.C33H37FN2O2S/c1-3-38-19-21-39(22-20-38)34(41)32(37-33(40)29-12-10-27(11-13-29)26-8-5-4-6-9-26)25-44(42,43)23-7-18-35(2)24-31(35)28-14-16-30(36)17-15-28;1-35(25-31(35)28-18-20-30(36)21-19-28)22-8-3-7-13-32(34(40)38-23-9-4-10-24-38)37-33(39)29-16-14-27(15-17-29)26-11-5-2-6-12-26;1-34(23-30(34)27-15-17-29(40-2)18-16-27)19-8-20-35-24-31(33(39)37-21-6-7-22-37)36-32(38)28-13-11-26(12-14-28)25-9-4-3-5-10-25;34-29-17-15-26(16-18-29)30-22-28(30)10-7-21-39-23-31(33(38)36-19-5-2-6-20-36)35-32(37)27-13-11-25(12-14-27)24-8-3-1-4-9-24/h4-6,8-17,31-32H,3,7,18-25H2,1-2H3,(H,37,40);2,5-6,11-12,14-21,31-32H,3-4,7-10,13,22-25H2,1H3,(H,37,39);3-5,9-18,30-31,35H,6-8,19-24H2,1-2H3,(H,36,38);1,3-4,8-9,11-18,28,30-31H,2,5-7,10,19-23H2,(H,35,37)/t2*31-,32-,35?;30-,31-,34?;28?,30-,31-/m0000/s1
InChIKeyYVHWPVATSAAVGC-WRXRVAJSSA-N
MW2244.98 g/mol
LogP25.46
Rot. Bonds46

About N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide

N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide (PubChem CID 162025491) has the molecular formula C137H161F3N10O11S2 and a molecular weight of 2244.98 g/mol. Its IUPAC name is N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide.

Molecular Properties

Compound NameN-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide
PubChem CID162025491
Molecular FormulaC137H161F3N10O11S2
Molecular Weight2244.98 g/mol
Exact Mass2243.17
IUPAC NameN-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide
SMILESCC1(CCCCC[C@H](NC(=O)c2ccc(-c3ccccc3)cc2)C(=O)N2CCCCC2)C[C@H]1c1ccc(F)cc1.CCN1CCN(C(=O)[C@H](CS(=O)(=O)CCCC2(C)C[C@H]2c2ccc(F)cc2)NC(=O)c2ccc(-c3ccccc3)cc2)CC1.COc1ccc([C@@H]2CC2(C)CCCNC[C@H](NC(=O)c2ccc(-c3ccccc3)cc2)C(=O)N2CCCC2)cc1.O=C(N[C@@H](CSCCCC1C[C@H]1c1ccc(F)cc1)C(=O)N1CCCCC1)c1ccc(-c2ccccc2)cc1
InChIInChI=1S/C35H42FN3O4S.C35H41FN2O2.C34H41N3O3.C33H37FN2O2S/c1-3-38-19-21-39(22-20-38)34(41)32(37-33(40)29-12-10-27(11-13-29)26-8-5-4-6-9-26)25-44(42,43)23-7-18-35(2)24-31(35)28-14-16-30(36)17-15-28;1-35(25-31(35)28-18-20-30(36)21-19-28)22-8-3-7-13-32(34(40)38-23-9-4-10-24-38)37-33(39)29-16-14-27(15-17-29)26-11-5-2-6-12-26;1-34(23-30(34)27-15-17-29(40-2)18-16-27)19-8-20-35-24-31(33(39)37-21-6-7-22-37)36-32(38)28-13-11-26(12-14-28)25-9-4-3-5-10-25;34-29-17-15-26(16-18-29)30-22-28(30)10-7-21-39-23-31(33(38)36-19-5-2-6-20-36)35-32(37)27-13-11-25(12-14-27)24-8-3-1-4-9-24/h4-6,8-17,31-32H,3,7,18-25H2,1-2H3,(H,37,40);2,5-6,11-12,14-21,31-32H,3-4,7-10,13,22-25H2,1H3,(H,37,39);3-5,9-18,30-31,35H,6-8,19-24H2,1-2H3,(H,36,38);1,3-4,8-9,11-18,28,30-31H,2,5-7,10,19-23H2,(H,35,37)/t2*31-,32-,35?;30-,31-,34?;28?,30-,31-/m0000/s1
InChIKeyYVHWPVATSAAVGC-WRXRVAJSSA-N
XLogP25.46
TPSA256.28 Ų
H-Bond Donors5
H-Bond Acceptors14
Rotatable Bonds46
Heavy Atoms163
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002244.98
LogP ≤ 525.46
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(2S)-1-(4-ethylpiperazin-1-yl)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxoheptan-2-yl]-4-fluorobenzamide;4-fluoro-N-[(2S)-7-[(2R)-2-(4-methoxyphenyl)cyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]benzamide;4-fluoro-N-[(2S)-7-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]benzamide;4-fluoro-N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propoxy]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]benzamide
CID 161483732
N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide
CID 159839257
4-fluoro-N-[(2S)-7-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]benzamide
CID 158160804
4-fluoro-N-[(2S)-7-[(2R)-2-(4-methoxyphenyl)cyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]benzamide
CID 158741301
N-[(2S)-5-[(1S,2S)-2-(4-fluorophenyl)cyclopropyl]-1-(4-methylsulfonylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(4-methoxyphenyl)benzamide
CID 161167727
N-[(2S)-5-[(1R,2R)-2-(4-fluorophenyl)cyclopropyl]-1-(4-methyl-3-oxopiperazin-1-yl)-1-oxopentan-2-yl]-4-phenylbenzamide
CID 147743921
N-[(2S)-5-[(1S,2S)-2-(4-fluorophenyl)cyclopropyl]-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-phenylbenzamide
CID 162155190
N-[(2S)-5-[(1S,2S)-2-(4-fluorophenyl)cyclopropyl]-1-(4-methylsulfonyl-3-oxopiperazin-1-yl)-1-oxopentan-2-yl]-6-methoxynaphthalene-2-carboxamide
CID 162096478
4-fluoro-N-[(2S)-7-[(2R)-2-(4-methylphenyl)cyclopropyl]-1-(4-methylsulfonylpiperazin-1-yl)-1-oxoheptan-2-yl]benzamide
CID 159046194
N-[(2S)-6-[[(2S)-2-(4-methoxyphenyl)cyclopropyl]amino]-1-(4-methylsulfonylpiperazin-1-yl)-1-oxohexan-2-yl]-4-phenylbenzamide
CID 129125107
N-[(2R)-3-[3-[(2R)-2-(4-methylphenyl)cyclopropyl]propylsulfonyl]-1-morpholin-4-yl-1-oxopropan-2-yl]benzamide
CID 157391635
N-[(2S)-7-[(1R,2R)-2-(4-methylphenyl)cyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-(trifluoromethyl)benzamide
CID 158533222

Frequently Asked Questions

What is the IUPAC name of N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide?
The IUPAC name of N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide (CID 162025491) is N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide.
What is the SMILES notation for N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide?
The canonical SMILES for N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide is CC1(CCCCC[C@H](NC(=O)c2ccc(-c3ccccc3)cc2)C(=O)N2CCCCC2)C[C@H]1c1ccc(F)cc1.CCN1CCN(C(=O)[C@H](CS(=O)(=O)CCCC2(C)C[C@H]2c2ccc(F)cc2)NC(=O)c2ccc(-c3ccccc3)cc2)CC1.COc1ccc([C@@H]2CC2(C)CCCNC[C@H](NC(=O)c2ccc(-c3ccccc3)cc2)C(=O)N2CCCC2)cc1.O=C(N[C@@H](CSCCCC1C[C@H]1c1ccc(F)cc1)C(=O)N1CCCCC1)c1ccc(-c2ccccc2)cc1.
What is the InChIKey of N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide?
The InChIKey is YVHWPVATSAAVGC-WRXRVAJSSA-N. The full InChI is InChI=1S/C35H42FN3O4S.C35H41FN2O2.C34H41N3O3.C33H37FN2O2S/c1-3-38-19-21-39(22-20-38)34(41)32(37-33(40)29-12-10-27(11-13-29)26-8-5-4-6-9-26)25-44(42,43)23-7-18-35(2)24-31(35)28-14-16-30(36)17-15-28;1-35(25-31(35)28-18-20-30(36)21-19-28)22-8-3-7-13-32(34(40)38-23-9-4-10-24-38)37-33(39)29-16-14-27(15-17-29)26-11-5-2-6-12-26;1-34(23-30(34)27-15-17-29(40-2)18-16-27)19-8-20-35-24-31(33(39)37-21-6-7-22-37)36-32(38)28-13-11-26(12-14-28)25-9-4-3-5-10-25;34-29-17-15-26(16-18-29)30-22-28(30)10-7-21-39-23-31(33(38)36-19-5-2-6-20-36)35-32(37)27-13-11-25(12-14-27)24-8-3-1-4-9-24/h4-6,8-17,31-32H,3,7,18-25H2,1-2H3,(H,37,40);2,5-6,11-12,14-21,31-32H,3-4,7-10,13,22-25H2,1H3,(H,37,39);3-5,9-18,30-31,35H,6-8,19-24H2,1-2H3,(H,36,38);1,3-4,8-9,11-18,28,30-31H,2,5-7,10,19-23H2,(H,35,37)/t2*31-,32-,35?;30-,31-,34?;28?,30-,31-/m0000/s1.
What are the key properties of N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide?
N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide has a molecular weight of 2244.98 g/mol, XLogP of 25.46, 46 rotatable bonds, 5 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2R)-1-(4-ethylpiperazin-1-yl)-3-[3-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]propylsulfonyl]-1-oxopropan-2-yl]-4-phenylbenzamide;N-[(2R)-3-[3-[(2R)-2-(4-fluorophenyl)cyclopropyl]propylsulfanyl]-1-oxo-1-piperidin-1-ylpropan-2-yl]-4-phenylbenzamide;N-[(2S)-7-[(2R)-2-(4-fluorophenyl)-1-methylcyclopropyl]-1-oxo-1-piperidin-1-ylheptan-2-yl]-4-phenylbenzamide;N-[(2S)-3-[3-[(2R)-2-(4-methoxyphenyl)-1-methylcyclopropyl]propylamino]-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]-4-phenylbenzamide is sourced from PubChem (CID 162025491), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).